![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
Retro Biosciences, backed by Sam Altman, is raising $1 billion to ...
Jan 24, 2025 · OpenAI CEO Sam Altman is doubling down on Retro Biosciences, a biotech startup based in San Francisco that wants humans to live 10 years longer than what it calls a healthy human lifespan....
OpenAI’s Sam Altman Invested $180M in Anti-Aging Biotech - AI …
May 11, 2023 · Sam Altman, CEO and co-founder of ChatGPT-maker OpenAI, is the sole backer of a startup trying to increase the lifespan of humans. In a venture round, the California-based Retro Biosciences raised $180 million from Altman, according to Crunchbase.
Sam Altman-backed AI biotech announces $1 billion for its lofty …
Feb 4, 2025 · Sam Altman, pictured at President Donald Trump's inauguration, is contributing to another round of funding for Retro Biosciences. The race to increase human life span through biotech just got...
Exclusive | Behind the billionaire-backed longevity business — and …
Jan 7, 2025 · PayPal cofounder Thiel, 57, forked over $1 million to the Methuselah Foundation, a biomedical charity that aims to make 90 the new 50 by 2030. OpenAI CEO Sam Altman (left), Amazon’s Jeff Bezos...
Sam Altman-backed Retro Biosciences to raise $1bn for project to …
Jan 23, 2025 · Retro Biosciences is raising a $1bn round to fund the artificial intelligence-powered biotech’s mission to increase human lifespan by a decade, starting by getting its first drug into trials this...
Sam Altman-backed startup vows to extend human life by 10 years
Dec 20, 2023 · Retro Biosciences, a startup with $180 million in funding from OpenAI’s Sam Altman, opened the doors to a laboratory that’s working to add a decade to every human’s life.
Sam Altman-backed AI biotech announces $1 billion for its lofty …
Feb 4, 2025 · Retro Biosciences, the AI-powered company whose mission is to develop therapies that reverse age-related disease, has just announced it's in the process of a $1 billion round of funding toward...
OpenAI CEO invests $180 million in biotech startup to reverse aging
Mar 9, 2023 · OpenAI CEO Sam Altman has turned out to be the investor that paid $180 million to get biotech startup Retro Biosciences off the ground, MIT Technology Review reported. The biotech company came...
ChatGPT Founder Sam Altman’s New Startup Retro Biosciences …
Mar 21, 2023 · Backed by the largest-ever individual investment towards a longevity startup from OpenAI CEO Sam Altman, Retro Biosciences will begin to tackle aging via cellular reprogramming, autophagy, and plasma-inspired therapeutics.
Sam Altman invested $180 million into a company trying to delay …
Mar 8, 2023 · Now MIT Technology Review can reveal that the entire sum was put up by Sam Altman, the 37-year-old startup guru and investor who is CEO of OpenAI. Altman spends nearly all his time at OpenAI,...
- Some results have been removed